Todos Medical Ltd. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Marketing Expenses

12 Months Ended

Dec. 31, 2019

NOTE 13 - MARKETING EXPENSES

	Year ended December 31
	2019		2018

Stock-based compensation (Note 10B7)	$	420,000	$	-
Professional fees		246,872		-
	$	666,872	$	-